论文部分内容阅读
在终末期肾病的贫血治疗上使用重组人类促红素(rHuEPO)后有了很大的改善,但该治疗经常伴随出现铁缺乏,而影响rHuEPO的治疗效果。因此有效使用rHuEPO需要长期补充铁剂。本项观察是比较静脉补充铁剂与口服铁剂治疗肾性贫血的临床疗效。1资料与方法1.1观察对象选取在我院2006—03~
There has been a dramatic improvement in the use of recombinant human erythropoietin (rHuEPO) in the treatment of anemia in end stage renal disease, but this treatment is often accompanied by an iron deficiency that affects the therapeutic efficacy of rHuEPO. Therefore, the effective use of rHuEPO requires long-term iron supplementation. This observation is to compare the clinical efficacy of intravenous iron supplementation and oral iron treatment of renal anemia. 1 Materials and Methods 1.1 The object of observation selected in our hospital 2006-03 ~